Acquired Autoimmune Hemophilia Following SARS-CoV-2 Vaccines: Dual-Drug Effects on Blood Coagulation and the Scylla and Charybdis Phenomenon
- 30 September 2021
- journal article
- editorial
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 121 (12) , 1555-1557
Abstract
Vaccination against the SARS-CoV-2 may lead to immunologic reactions activating the haemostatic system and resulting in both venous and arterial thromboembolism. Aquired autoimmune Haemophilia following SARS-CoV-2 vaccines were now reported 15 to 19 days (or later) after vaccination and resolution of symptoms by adequate treatment of the immunologic reaction. From patients’ point of view, anticoagulants and SARS-CoV-2 vaccines share their capacity to induce thrombosis as well as bleeding and clinicians are subjected to Scylla and Charybdis when they treat patients not only with anticoagulants but also with SARS-CoV-2 vaccines. Careful analysis of coincidence and causality requires attention when reporting on acquired coagulation inhibitors regarding severity, treatments, duration and statistical risk. Received: 21 September 2021 Accepted: 28 September 2021 Publication Date: 30 September 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, GermanyKeywords
This publication has 28 references indexed in Scilit:
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UKThe Lancet, 2021
- Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regionsJournal of Neurology, Neurosurgery & Psychiatry, 2020
- Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19Thrombosis and Haemostasis, 2020
- Characterization of New Monoclonal PF4-Specific Antibodies as Useful Tools for Studies on Typical and Autoimmune Heparin-Induced ThrombocytopeniaThrombosis and Haemostasis, 2020
- Staging Severity of COVID-19 according to Hemostatic Abnormalities (CAHA Score)Thrombosis and Haemostasis, 2020
- Different Hypercoagulable Profiles in Patients with COVID-19 Admitted to the Internal Medicine Ward and the Intensive Care UnitThrombosis and Haemostasis, 2020
- Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future ResearchThrombosis and Haemostasis, 2020
- The first case of acquired hemophilia A associated with SARS‐CoV‐2 infectionAmerican Journal of Hematology, 2020
- Immune pathogenesis of heparin-induced thrombocytopeniaThrombosis and Haemostasis, 2016
- Development of Factor Vlll:C Inhibitors Following VaccinationActa Haematologica, 1996